Interactions between antiinfective agents and immunosuppressants

American Journal of Transplantation

Volumn 9, Issue SUPPL. 4, 2009, Pages

  Thomas, L D ^a   Miller, G G ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antibiotics; Drug interactions; Immunosuppressants; Transplant

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; ANIDULAFUNGIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; AZITHROMYCIN; CALCINEURIN INHIBITOR; CASPOFUNGIN; CIDOFOVIR; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOSPORIN A; EFAVIRENZ; GATIFLOXACIN; GENTAMICIN; IMMUNOSUPPRESSIVE AGENT; LEVOFLOXACIN; MACROLIDE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MICAFUNGIN; MOXIFLOXACIN; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEVIRAPINE; OFLOXACIN; RAPAMYCIN; RIFABUTIN; STAVUDINE; SULFONAMIDE; TACROLIMUS; TELITHROMYCIN; UNINDEXED DRUG; VALGANCICLOVIR; ZIDOVUDINE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; BONE MARROW SUPPRESSION; CALCIUM BLOOD LEVEL; DRUG ANTAGONISM; DRUG MECHANISM; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LIVER TOXICITY; MAGNESIUM BLOOD LEVEL; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; SHORT SURVEY; SIDE EFFECT; TREATMENT INDICATION;

ANTI-INFECTIVE AGENTS; DRUG INTERACTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION;

EID: 72949099524     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02918.x     Document Type: Short Survey

References (17)

1. Page RL, Ruscin JM, Fish D, Lapointe M. Possible interaction between intravenous azithromycin and oral cyclosporine. Pharmacotherapy 2001 21 : 1436 1443.
2. Ljutic D, Rumboldt Z. Possible interaction between azithromycin and cyclosporin: A case report. Nephron 1995 70 : 130.
3. Surowiec D, DePestel DD, Carver PL. Concurrent administration of sirolimus and voriconazole: A pilot study assessing safety and approaches to appropriate management. Pharmacotherapy 2008 28 : 719 729.
4. Marr KA, Hachem R, Papanicolaou G et al. Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A. Transpl Infect Dis 2004 6 : 110 116.
5. Hebert MF, Townsend RW, Austin S et al. Concomitant cyclosporine and micafungin pharmacokinetics in healthy volunteers. J Clin Pharmacol 2005 45 : 954 960.
6. Dowell JA, Stoqniew M, Krause D, Henkel T, Weston IE. Assessment of the safety and pharmacokinetics of anidulafungin when administered with cyclosporine. J Clin Pharmacol 2005 45 : 227 233.
7. Frassetto LA, Browne M, Cheng A et al. Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. Am J Transplant 2007 7 : 2816 2820.
8. Frassetto L, Baluom M, Jacobsen W et al. Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients. Transplantation 2005 80 : 13 17.
9. Teicher E, Vincent I, Bonhomme-Faivre L et al. Effect of highly active antiretroviral therapy on tacrolimus pharmacokinetics in hepatitis C virus and HIV co-infected liver transplant recipients in the ANRS HC-08 study. Clin Pharmacokinet 2007 46 : 941 952.
10. Margolis D, Heredia A, Gaywee J, Oldach D, Drusano G, Redfield R. Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity. J Acquir Immune Defic Syndr 1999 21 : 362 370.
11. Tricot L, Teicher E, Peytavin G et al. Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. Am J Transplant 2009 9 : 1946 1952.
12. Lopez-Montes A, Gallego E, Lopez E et al. Treatment of tuberculosis with rifabutin in a renal transplant recipient. Am J Kidney Dis 2004 44 : e59 e63.
13. Chenhsu RY, Loong CC, Chou MH, Lin MF, Yang WC. Renal allograft dysfunction associated with rifampin-tacrolimus interaction. Ann Pharmacother 2000 34 : 27 31.
14. Modry DL, Stinson EB, Oyer PE, Jamieson SW, Baldwin JC, Shumway NE. Acute rejection and massive cyclosporine requirements in heart transplant recipients treated with rifampin. Transplantation 1985 39 : 313 314.
15. Zimmerman JJ. Exposure-response relationships and drug interactions of sirolimus. AAPS J 2004 6 : 1 12.
16. Naesens M, Kuypers DR, Streit F et al. Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: Implications for drug exposure in renal allograft recipients. Clin Pharmacol Ther 2006 80 : 509 521.
17. Pea F, Tavio M, Pavan F et al. Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients. Antivir Ther 2008 13 : 739 742.